MGX Metagenomi Projected Future Earnings

Symbol and logo of brand Metagenomi, Inc. (MGX)

Metagenomi, Inc. (MGX) is investing in the discovery of new CRISPR systems to combat hereditary pathologies. Developing precision editing tools in alliance with biotech giants minimizes risks. The company's pre-revenue status makes it dependent on investor capital. Expected profit growth demonstrates the dynamics of market expectations, and reflects the latest metric value determining the current valuation of future prospects.

MGX: Metagenomi, Inc. Expected Net Profit 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for Metagenomi Therapeutics (MGX)

- share price and consensus valuation forecast:
Comprehensive company analysis:Metagenomi Inc., MGX
Core merchandise of Metagenomi, Inc

Projected profit reflects the expected net return of the business, accounting for future cash flows. By analyzing this chart of estimated future earnings, an investor assesses the asset's capitalization potential. This metric synthesizes current margins and revenue growth rates. For Metagenomi, Inc. (MGX), the stability of this indicator confirms the effectiveness of pipeline diversification across oncology and genetics. Partnerships with pharma behemoths reduce expectation volatility, minimizing early-stage development risks.

Competitor analysis

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|PRME: Projected Future Earnings|Taysha - Expected Net Income|Expected Profit uniQure NV|Net Profit Forecast MGTX (MeiraGTx PLC)|Future Profit RGNX (regenxbio.com)|Solid Biosciences Inc. - Net Profit Forecast|Expected Profit Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Expected Net Profit|BNTC - Expected Profit|Design Pharma - Future Net Profit|RCKT (Rocket Pharmaceuticals Inc) - Future Profit|4D Molecular Therapeutics (FDMT) - Projected Future Earnings|Expected Profit Lexeo Therapeutics, Inc.|Expected Net Profit Korro Bio, Inc. KRRO|Projected Future Earnings EDIT|Company Profit Forecast Silence Therapeutics Corp|Expected Profit proqr.com PRQR|CDXS - Future Profit|SGMO - Expected Profit|Projected Net Profit Nautilus Biotechnology, Inc. (NAUT)|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings